Axcelis Technologies
ACLS
138.40
-2.75
-1.95%
Axcelis Technologies
US · ACLS
#2213 by market cap
Listed 1970
138.40
-2.75
-1.95%
Live - 5344 symbols - heartbeat 379s ago
· 2026-10-08 07:39
Pre-market
134.01
-3.17%
After-hours
140.26
+1.34%
- Market cap
- 4.27B
- P/E (TTM)i
- 46.44
- P/Bi
- 4.01
- EPSi
- 3.80
- Div yieldi
- 0.00%
- 52W posi
- 54%
Reader sentiment
Are you bullish or bearish on ACLS?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 9.93, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year -17.57% YoY
Margins
- Gross margin
- 44.91%
- Operating margin
- 14.22%
- Net margin
- 14.33%
Key ratios & quality
- Altman Z-Scorei
- 9.93
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 442.58M | 342.96M | 474.56M | 662.43M | 920.00M | 1.13B | 1.02B | 839.05M |
| Gross profit | 179.64M | 144.15M | 198.58M | 286.45M | 401.79M | 491.30M | 454.65M | 376.85M |
| Selling & admin expenses | 67.80M | 66.02M | 78.71M | 93.69M | 111.07M | 128.60M | 138.36M | 148.58M |
| Research & development | 51.88M | 53.93M | 61.83M | 65.43M | 78.36M | 96.91M | 105.50M | 108.96M |
| Operating profit | 59.96M | 24.21M | 58.04M | 127.33M | 212.36M | 265.80M | 210.79M | 119.32M |
| Pretax profit | 54.71M | 20.92M | 55.89M | 120.43M | 204.89M | 278.60M | 230.27M | 138.25M |
| Tax | 8.82M | 3.89M | 5.90M | 21.78M | 21.81M | 32.34M | 29.28M | 18.01M |
| Net profit | 45.89M | 17.03M | 49.98M | 98.65M | 183.08M | 246.26M | 200.99M | 120.24M |
| Basic EPS | 1 | 1 | 2 | 3 | 6 | 8 | 6 | 4 |
| Diluted EPS | 1.35 | 0.50 | 1.46 | 2.88 | 5.46 | 7.43 | 6.15 | 3.80 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 192.56M | 194.54M | 213.61M | 238.33M | 198.96M | 215.18M |
| Gross profit | 88.77M | 87.34M | 88.81M | 111.93M | 80.58M | 91.19M |
| Selling & admin expenses | 32.48M | 31.31M | 39.15M | 45.63M | 44.12M | 41.93M |
| Research & development | 27.13M | 27.06M | 24.64M | 30.13M | 28.52M | 28.98M |
| Operating profit | 29.16M | 28.97M | 25.02M | 36.17M | 7.95M | 20.28M |
| Pretax profit | 33.08M | 35.00M | 30.15M | 40.02M | 10.63M | 25.35M |
| Tax | 4.51M | 3.62M | 4.16M | 5.72M | 1.41M | 2.06M |
| Net profit | 28.58M | 31.38M | 25.99M | 34.30M | 9.21M | 23.29M |
| Basic EPS | 1 | 1 | 1 | 1 | 0 | 1 |
| Diluted EPS | 0.88 | 0.98 | 0.83 | 1.10 | 0.30 | 0.75 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 396.77M | 375.68M | 470.79M | 619.25M | 877.65M | 1.08B | 1.12B | 943.20M |
| Cash & ST investments | 177.99M | 139.88M | 203.48M | 294.92M | 432.17M | 506.15M | 571.34M | 374.25M |
| Inventory | 129.00M | 140.36M | 161.08M | 194.98M | 242.41M | 306.48M | 282.23M | 329.01M |
| Total assets | 548.44M | 548.09M | 624.62M | 753.24M | 1.01B | 1.28B | 1.35B | 1.36B |
| Total current liabilities | 85.00M | 68.66M | 84.43M | 150.14M | 248.13M | 285.13M | 207.52M | 197.66M |
| Short-term debt | -- | 399.00K | 756.00K | 979.00K | 1.23M | 1.51M | 1.35M | 1.58M |
| Long-term debt | -- | -- | -- | -- | -- | -- | -- | -- |
| Total liabilities | 140,104,000.00 | 128,667,000.00 | 143,022,000.00 | 214,281,000.00 | 346,385,000.00 | 417,085,000.00 | 335,991,000.00 | 326,674,000.00 |
| Total equity | 408.34M | 419.43M | 481.60M | 538.96M | 667.26M | 864.88M | 1.01B | 1.03B |
| Retained earnings | -157.26M | -140.23M | -91.97M | -22.72M | 118.89M | 319.51M | 470.32M | 503.54M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 1.11B | 1.06B | 984.03M | 943.20M | 935.68M | 979.77M |
| Cash & ST investments | 587.06M | 549.84M | 449.56M | 374.25M | 366.60M | 402.22M |
| Inventory | 295.85M | 310.77M | 324.34M | 329.01M | 326.05M | 338.17M |
| Total assets | 1.34B | 1.32B | 1.35B | 1.36B | 1.37B | 1.39B |
| Total current liabilities | 200.37M | 177.11M | 198.99M | 197.66M | 203.91M | 200.10M |
| Short-term debt | 1.37M | 1.44M | 1.51M | 1.58M | 1.65M | 1.72M |
| Long-term debt | -- | -- | -- | -- | -- | -- |
| Total liabilities | 313,380,000.00 | 301,103,000.00 | 331,796,000.00 | 326,674,000.00 | 329,901,000.00 | 321,017,000.00 |
| Total equity | 1.03B | 1.02B | 1.02B | 1.03B | 1.04B | 1.07B |
| Retained earnings | 485.67M | 487.16M | 488.77M | 503.54M | 512.75M | 536.04M |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 46.97M | -13.59M | 69.70M | 150.19M | 215.61M | 156.87M | 140.82M | 118.31M |
| Depreciation & amortization | 5.77M | 7.88M | 9.94M | 10.82M | 11.61M | 13.07M | 15.81M | 17.61M |
| Free cash flow | 42.25M | -25.56M | 62.27M | 141.47M | 204.92M | 136.21M | 128.64M | 107.01M |
| Dividends paid | -- | -- | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | 0 | -17.74M | -7.50M | -49.99M | -57.50M | -52.50M | -60.49M | -121.08M |
| Ending cash balance | 184.90M | 146.53M | 204.23M | 295.68M | 186.35M | 173.95M | 131.06M | 156.08M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 39.80M | 39.73M | 45.35M | -6.57M | 18.14M | 18.37M |
| Depreciation & amortization | 4.31M | 4.52M | 4.33M | 4.46M | 4.44M | 4.44M |
| Free cash flow | 34.84M | 37.74M | 43.34M | -8.90M | 16.30M | 14.82M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -18.18M | -45.34M | -32.34M | -25.23M | 0 | -244.00K |
| Ending cash balance | 191.51M | 181.28M | 195.13M | 156.08M | 161.46M | 165.63M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 12.04 | 4.12 | 11.09 | 19.33 | 30.36 | 32.15 | 21.41 | 11.75 |
| ROA %i | 8.85 | 3.11 | 8.52 | 14.32 | 20.72 | 21.46 | 15.28 | 8.87 |
| ROIC %i | 11.25 | 4.07 | 10.82 | 18.36 | 28.31 | 28.93 | 18.76 | 9.96 |
| 5-year avg ROE %i | 13.06 | 15.19 | 15.74 | 18.47 | 15.39 | 19.41 | 22.87 | 23.00 |
| EBIT margin %i | 13.52 | 7.60 | 12.87 | 18.91 | 22.88 | 25.11 | 23.16 | 17.12 |
| FCF / sales %i | 9.55 | -- | 13.12 | 21.36 | 22.27 | 12.05 | 12.64 | 12.75 |
| Current ratioi | 4.67 | 5.47 | 5.58 | 4.12 | 3.54 | 3.79 | 5.41 | 4.77 |
| Quick ratioi | 3.02 | 3.26 | 3.44 | 2.66 | 2.43 | 2.54 | 3.73 | 2.75 |
| Debt / assetsi | 8.71 | 8.86 | 7.71 | 6.29 | 4.58 | 3.52 | 3.24 | 3.11 |
| LT debt / equityi | 11.70 | 11.48 | 9.84 | 8.61 | 6.77 | 5.05 | 4.18 | 3.94 |
| Interest coveragei | 11.71 | 5.06 | 11.72 | 25.91 | 37.74 | 53.10 | 43.16 | 26.77 |
| Revenue CAGR (3Y) %i | 13.65 | 8.71 | 4.95 | 14.39 | 38.95 | 33.56 | 15.39 | -3.02 |
| Net income CAGR (3Y) %i | 46.22 | 15.69 | -26.71 | 29.07 | 120.69 | 70.16 | 26.77 | -13.08 |
| FCF CAGR (3Y) %i | 36.98 | -- | 8.32 | 49.61 | -- | 29.81 | -3.12 | -19.47 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 18.45 | 16.19 | 13.62 | 11.75 | 9.74 | 8.89 |
| ROA %i | 13.45 | 12.14 | 10.10 | 8.87 | 7.43 | 6.85 |
| ROIC %i | 16.01 | 13.93 | 11.61 | 9.96 | 8.14 | 7.39 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 21.90 | 20.93 | 19.03 | 17.12 | 14.32 | 12.86 |
| FCF / sales %i | 12.82 | 13.68 | 14.54 | 12.75 | 10.47 | 7.57 |
| Current ratioi | 5.56 | 6.01 | 4.95 | 4.77 | 4.59 | 4.90 |
| Quick ratioi | 3.75 | 3.89 | 3.00 | 2.75 | 2.59 | 2.78 |
| Debt / assetsi | 3.23 | 3.25 | 3.16 | 3.11 | 3.05 | 3.00 |
| LT debt / equityi | 4.08 | 4.07 | 4.04 | 3.94 | 3.86 | 3.74 |
| Interest coveragei | 38.27 | 34.11 | 29.66 | 26.77 | 22.89 | 21.43 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Single-engine
- Product is the largest reported line at 93.17% of revenue, across 2 reported segments.
- The next-largest line, Services, is a distant second at 6.83% - a sharp slowdown here would have little to offset it.
Revenue breakdown most recent period
Business
Product93.17%
Services6.83%
Quote time 2026-10-08 07:39:13 · For reference only, not investment advice and not tailored to your situation.